Capula Management LTD Agios Pharmaceuticals, Inc. Transaction History

Capula Management LTD

  • $9.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$21.38 - $29.19 $86,802 - $118,511
4,060 Added 19.98%
24,380 $690,000
Q1 2023

May 10, 2023
SELL
$21.74 - $30.93 $276,098 - $392,811
-12,700 Reduced 38.46%
20,320 $466,000
Q4 2022

Feb 14, 2023
BUY
$24.81 - $31.52 $819,226 - $1.04 Million
33,020 New
33,020 $927,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email